Company:  INMUNE BIO, INC. (INMB)
Form Type:  8-K
Filing Date:  8/13/2019 
CIK:  0001711754 
Address:  1200 PROSPECT STREET
SUITE 525
 
City, State, Zip:  LA JOLLA, California 92037 
Telephone:  (858) 964-3720 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.32  
Change: 
-0.5666 (-9.62%)  
Trade Time: 
Aug 16  
Market Cap: 
$57.49M
Trade INMB now with 

© 2019  
Description of Business
Our objective is to develop and commercialize our product candidates to treat diseases where the innate immune system is not functioning normally and contributing to the patient's disease. This can be in cancer where Natural Killer ("NK") cells are inactive and contribute to a tumor's evasion of the immune system and/or disease progression while Myeloid Derived Suppressor Cells ("MDSC") proliferate to protect the tumor from attack by the patient's immune system or this can be other diseases such as neurologic and metabolic diseases where chronic inflammation results in innate immune system dysfunction and disease progression. Our initial focus will be the treatment of cancer solid tumors and treatment of Alzheimer's Disease.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial statements and Exhibits
    SIGNATURE
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT
    CASH FLOW